Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Emerging therapies expected to make a difference in Parkinson's disease management.

Four therapeutic approaches that are likely to influence PD management in the coming years are discussed: continuous subcutaneous levodopa infusion, cell-based dopamine replacement, immunotherapies targeting α-synuclein, and gene transfer therapies.

Andy Y. An, L. Kalia · 0 citations
Editorial Open access Sep 2026

Co- and multipathologies need serious consideration for understanding Parkinson's disease pathogenesis and designing novel experimental therapeutic strategies

Investigation of anti-α -synuclein immunotherapy as a potential disease-modifying strategy for PD found no evidence of delay in motor progression and exploratory studies suggested potential clinical activity.

A. Boehringer, L. Kalia, B. Bloem et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.